| ¿µ¹® | white blood cell(WBC), leukocyte | ÇÑ±Û | ¹éÇ÷±¸ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, ȤÀº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀÎ Çö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | whole blood | ÇÑ±Û | ÀüÇ÷, ¿ÂÇ÷¾× |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÀÇ ¸ðµç ¼ººÐÀÌ Çϳªµµ Á¦°ÅµÇÁö ¾ÊÀº ¿ÂÀüÇÑ Ç÷¾×. ÀüÇ÷Àº ¾ö°ÝÇÑ ¹«±ÕÁ¶°ÇÇÏ¿¡¼, ¼±º°ÇÑ °øÇ÷ÀڷκÎÅÍ Ã¤ÃëÇÑ °ÍÀ̸ç, ±¸¿¬»ê ÀÌ¿ÂÀ̳ª ÇìÆÄ¸° °°Àº Ç×ÀÀ°øÁ¦·Î ÀÀ°í¸¦ ¹æÁöÇÏ¿© Ç÷¾×º¸Ãæ ¸ñÀûÀ¸·Î »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | blood collection | ÇÑ±Û | äÇ÷ |
|---|---|---|---|
| ¼³¸í | 1. ¸ð¼¼°üÇ÷ : Ç÷±¸¼ö-Ç÷¼ÒÆÇ¼ö °è»ê, Ç÷»ö¼Ò·®, Ç÷±¸¿ëÀûÃøÁ¤, µµ¸»Ç¥º»Á¦ÀÛ µîÀ» ÇÒ¶§ »ç¿ëµÈ´Ù. ±ÓºÒ ¶Ç´Â ¼Õ°¡¶ô³¡¹Ù´Ú¸éÀ» ÃæºÐÈ÷ ¸¶ÂûÇÑ ´ÙÀ½, ¾ËÄڿ÷Π¼Òµ¶-°ÇÁ¶½ÃÄѼ, ÀÛÀº Ä® ¶Ç´Â Á¾µÎħ ȤÀº 1mmÀÇ ÁÖ»çħÀ¸·Î 2~3mmÀÇ ±íÀ̱îÁö Â´Ù. ¸ÇóÀ½ Çǹæ¿ïÀº ´Û¾Æ³½ ÈÄ ´ÙÀ½ Ç͹æ¿ïÀ» °Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 2. Á¤¸ÆÇ÷ : ´ë·®ÀÇ Ç÷¾×À» ¿äÇÏ´Â °æ¿ì¿¡ »ç¿ëÇÑ´Ù. º¸Åë (ÆÈ²ÞÄ¡Á¤ÁßÇǺÎ)ÁÖÁ¤ÁßÇÇÁ¤¸ÆÀ» Â¸ç, ¿µÀ¯¾ÆÀÇ °æ¿ì¿¡´Â ¿Ü°æÁ¤¸ÆÀ» ¼±ÅÃÇϱ⵵ ÇÑ´Ù. ÁöÇ÷¿ë °í¹«ÁÙ·Î »ó´ÜÀ» ÃÖÀúÇ÷¾Ð¿¡ »ó´çÇÏ´Â Á¤µµ·Î ¹°í, ÁÖ¸ÔÀ» ²À Áã°Ô ÇÏ¿© Á¤¸ÆÀ» ³ëÃâ½ÃŲ ÈÄ ¸ê±Õ°ÇÁ¶ÁÖ»ç±â¸¦ Ç÷°ü³»¿¡ »ðÀÔÇÑ´Ù. °ð ¹Ù·Î °í¹«ÁÙ°ú ÁÖ¸ÔÀ» Ç®°í äÇ÷À» ÇÑ ´ÙÀ½ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö´Â´Ù. 2ºÐÀÌ»óÀÇ Á¤¸Æ ¿ïÇ÷Àº Ç÷¾×¼º»ó¿¡ º¯È¸¦ °¡Á®¿Â´Ù. 2. µ¿¸ÆÇ÷ : À§ÆÈµ¿¸Æ ¶Ç´Â ³Ò´Ù¸® µ¿¸ÆÀ» »ç¿ëÇÏ¿© õÀںθ¦ ¼Òµ¶ÇÑ ´ÙÀ½, ÇÁ·ÎÄ«ÀÎ ±¹¼Ò¸¶Ã븦 ÇÑ´Ù. äÇ÷ÀÚ ¿Þ¼ÕÀÇ °¡¿îµ¥¼Õ°¡¶ô°ú µÑ°¼Õ°¡¶ôÀ¸·Î µ¿¸ÆÀ» °íÁ¤Çϰí, ÁÖ»çħÀ» µ¿¸Æ¿¡ 45~65¡ÉÀÇ °¢µµ·Î Âñ·¯ ³Ö¾î äÇ÷ ÈÄ ¸öÂʵ¿¸ÆÀ» ¾öÁö¼Õ°¡¶ôÀ¸·Î ¾Ð¹ÚÇÏ¸é¼ ÁÖ»çħÀ» »©°í, ±× µÚ 5ºÐ°£Âë Â ºÎÀ§¸¦ ¾Ð¹ÚÇÑ´Ù. |
||
| ¿µ¹® | blood-brain barrier(BBB) | ÇÑ±Û | Ç÷³úÀ庮 |
|---|---|---|---|
| ¼³¸í | ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù. |
||
| F2R | [blood coagulation] factor II receptor |
|---|---|
| IVBC | intravascular blood coagulation |
| CBF | capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo... |
| HBF | hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala... |
| DIC | Disseminated(=Diffuse) Intravascular Coagulation syndrome; ÆÄÁ¾¼ºÇ÷°ü³»ÀÀ°í(÷ëðúàõúìηҮëêͳ) ÁõÈıº = ... |
| coagulation vitamin | An obsolete term for vitamin K. (05 Mar 2000) |
|---|---|
| heat coagulation test | A test for measurement of protein in urine; albumin and globulin are coagulated by heat at an acid pH, and the amount of turbidity present provides a qualitative estimation of the degree of proteinuria. (05 Mar 2000) |
| disseminated intravascular coagulation | <haematology> Complication of septic shock in which endotoxin (from gram-negative bacteria) induces systemic clotting of the blood, probably indirectly through the effect of endotoxin on neutrophils. It may also develop in other situations where neutrophils become systemically hyperactivated. Acronym: DIC (11 Jan 1998) |
| laser coagulation | The coagulation of tissues using lasers. These lasers produce light in the visible green wavelength that is selectively absorbed by haemoglobin, and thus it is possible to seal bleeding blood vessels. (12 Dec 1998) |
| light coagulation | The coagulation of tissue by an intense beam of light, including laser (laser coagulation). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, haemorrhages, and malignant and benign neoplasms. (12 Dec 1998) |
| lipoprotein-associated coagulation inhibitor | Formerly known as anticonvertin; a protein that inhibits the extrinsic pathway of coagulation by binding to the tissue factor III-factor VII-Calcium-factor Xa complex. (05 Mar 2000) |
| lupus coagulation inhibitor | An antiphospholipid antibody found in association with systemic lupus erythematosus (lupus erythematosus, systemic), antiphospholipid syndrome, and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including foetal death and spontaneous abortion, as well as a variety of haematologic and neurologic complications. (12 Dec 1998) |
| adjustment disorders | Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor. (12 Dec 1998) |
| affective disorders | A class of mental disorder's characterised by a disturbance in mood. (05 Mar 2000) |
| affective disorders, psychotic | Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc. (12 Dec 1998) |
| alcohol-related disorders | Mental disorders related or resulting from abuse or mis-use of alcohol. (12 Dec 1998) |
| amphetamine-related disorders | Disorders related or resulting from use of amphetamines. (12 Dec 1998) |
| anxiety disorders | Disorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance. (12 Dec 1998) |
| articulation disorders | Disorders of speech sound production characterised by substitution, omission, and distortion of sounds. (12 Dec 1998) |
| auditory perceptual disorders | Disorders of auditory perception manifesting as difficulties with auditory memory, speech perception and sound localization. Lesions are usually in the temporal lobe. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|